Evidence against KSHV infection in the pathogenesis of multiple myeloma.

[1]  K. Tarte,et al.  Clinical-grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi's sarcoma-associated herpesvirus. , 1998, Blood.

[2]  M. Moroni,et al.  Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. , 1997, Science.

[3]  G. Pinkus,et al.  Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. , 1997, Blood.

[4]  K. Tarte,et al.  Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma. , 1997, Blood.

[5]  G. Morgan,et al.  HHV-8 and multiple myeloma in the UK , 1997, The Lancet.

[6]  V. Calvez,et al.  HHV-8 and multiple myeloma in France , 1997, The Lancet.

[7]  L. Rainbow,et al.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen , 1997, Journal of virology.

[8]  J. Said,et al.  Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. , 1997, Science.

[9]  R. Sun,et al.  Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells , 1997, Journal of virology.

[10]  C. Boshoff,et al.  Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.

[11]  P. Simmonds,et al.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.

[12]  J. Phair,et al.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.

[13]  J. Phair,et al.  Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. , 1996, The New England journal of medicine.

[14]  T. Rose,et al.  Detection and analysis of diverse herpesviral species by consensus primer PCR , 1996, Journal of clinical microbiology.

[15]  D R Hoover,et al.  Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.

[16]  G. Gaidano,et al.  Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain , 1995, British journal of haematology.

[17]  F. Sigaux,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.

[18]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[19]  B. Klein,et al.  Interleukin-6 in human multiple myeloma. , 1995, Blood.

[20]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[21]  H. Haverkos,et al.  Prevalence of Kaposi's sarcoma among patients with AIDS. , 1985, The New England journal of medicine.

[22]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. , 1997, Science.

[23]  O. Cope,et al.  Multiple myeloma. , 1948, The New England journal of medicine.